Trending NewsTrending NewsNASDAQ:TEM Tempus AI (TEM) Stock Price, News & Analysis $77.19 -0.84 (-1.08%) Closing price 04:00 PM EasternExtended Trading$77.19 0.00 (0.00%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Tempus AI Stock (NASDAQ:TEM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Tempus AI alerts:Sign Up Key Stats Today's Range$75.81▼$79.0050-Day Range$41.55▼$80.3652-Week Range$40.77▼$104.32Volume5.97 million shsAverage Volume6.14 million shsMarket Capitalization$13.93 billionP/E RatioN/ADividend YieldN/APrice Target$69.63Consensus RatingHold Company Overview Tempus AI, Inc. is a healthcare technology company focused on applying artificial intelligence and data analytics to precision medicine. The company combines molecular testing, clinical data and machine learning to help physicians make more informed treatment decisions and support the development of new therapies. Tempus provides genomic and diagnostic testing services, including testing intended to identify clinically relevant mutations and other biomarkers. Its technology platform also organizes and analyzes clinical and molecular data, while its AI-enabled tools are designed to assist healthcare professionals with patient care, research and workflow management. The company serves healthcare providers, patients, pharmaceutical companies and biotechnology researchers, primarily in the United States. Tempus was founded in 2015 by Eric Lefkofsky, who serves as its chief executive officer. The company became publicly traded on the Nasdaq under the symbol TEM in 2024.AI Generated. May Contain Errors. Read More Tempus AI Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreTEM MarketRank™: Tempus AI scored higher than 37% of companies evaluated by MarketBeat, and ranked 666th out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingTempus AI has received a consensus rating of Hold. The company's average rating score is 2.41, and is based on no strong buy ratings, 11 buy ratings, 9 hold ratings, and 2 sell ratings.Downside RiskTempus AI has a consensus price target of $69.63, representing about 9.7% downside from its current price of $77.07.Amount of Analyst CoverageTempus AI has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Tempus AI's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Tempus AI are expected to grow in the coming year, from ($1.38) to ($1.00) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tempus AI is -53.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tempus AI is -53.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTempus AI has a P/B Ratio of 27.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Tempus AI's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted21.56% of the float of Tempus AI has been sold short.Short Interest Ratio / Days to CoverTempus AI has a short interest ratio ("days to cover") of 2.92, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tempus AI has recently decreased by 1.36%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTempus AI does not currently pay a dividend.Dividend GrowthTempus AI does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.50 News SentimentTempus AI has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 40 news articles for Tempus AI this week, compared to 10 articles on an average week.Search InterestOnly 47 people have searched for TEM on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.MarketBeat Follows20 people have added Tempus AI to their MarketBeat watchlist in the last 30 days. This is an increase of 54% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Tempus AI insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $73,877,392.00 in company stock.Percentage Held by Insiders24.26% of the stock of Tempus AI is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions24.22% of the stock of Tempus AI is held by institutions.Read more about Tempus AI's insider trading history. Receive TEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tempus AI and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TEM Stock News Headlines3 Analysts, 3 Trades to Make Today26 minutes ago | investorplace.comTempus AI: High Risk, But With A Great CauseSeptember 22 at 8:00 AM | seekingalpha.comBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25.September 22 at 1:00 AM | Paradigm Press (Ad)Tempus AI (NASDAQ:TEM) Rating Increased to Hold at The Goldman Sachs GroupSeptember 22 at 7:36 AM | americanbankingnews.comTempus AI: Data And Applications Will Unlock More UpsideSeptember 21 at 12:00 AM | seekingalpha.comInsider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $49,000.00 in StockSeptember 19 at 7:07 AM | insidertrades.comTempus AI (NASDAQ:TEM) Director Nadja West Sells 3,000 SharesSeptember 2, 2026 | insidertrades.comTempus AI (NASDAQ:TEM) CEO Ryan Fukushima Sells 14,286 Shares of StockAugust 26, 2026 | insidertrades.comSee More Headlines TEM Stock Analysis - Frequently Asked Questions How have TEM shares performed this year? Tempus AI's stock was trading at $59.05 at the beginning of the year. Since then, TEM shares have increased by 30.5% and is now trading at $77.0740. How were Tempus AI's earnings last quarter? Tempus AI, Inc. (NASDAQ:TEM) released its quarterly earnings results on Thursday, July, 30th. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.10. The company's revenue was up 21.6% compared to the same quarter last year. Read the conference call transcript. When did Tempus AI IPO? Tempus AI (TEM) raised $400 million in an initial public offering (IPO) on Wednesday, June 12th 2024. The company issued 11,100,000 shares at a price of $35.00-$37.00 per share. Who are Tempus AI's major shareholders? Tempus AI's top institutional investors include Wellington Management Group LLP (0.22%), California State Teachers Retirement System (0.07%), Washington Trust Advisors Inc. (0.05%) and Headlands Technologies LLC (0.03%). Insiders that own company stock include Bradley A Keywell, Eric P Lefkofsky, Andrew Polovin, James William Rogers, Erik Phelps, Ryan M Bartolucci, Nadja West, David R Epstein, Jennifer A Doudna and Ryan Fukushima. View institutional ownership trends. How do I buy shares of Tempus AI? Shares of TEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tempus AI own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tempus AI investors own include AST SpaceMobile (ASTS), NVIDIA (NVDA), Broadcom (AVGO), Micron Technology (MU), Recursion Pharmaceuticals (RXRX), Genius Sports (GENI) and Super Micro Computer (SMCI). Company Calendar Last Earnings7/30/2026Today9/22/2026Next Earnings (Estimated)11/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 TEM's financial health is in the Green zone, according to TradeSmith. TEM has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:TEM Previous SymbolNASDAQ:TEM CIK1717115 Webwww.tempus.com Phone800-976-5448FaxN/AEmployees3,800Year Founded2015Price Target and Rating Average Price Target for Tempus AI$69.63 High Price Target$100.00 Low Price Target$35.00 Potential Upside/Downside-9.8%Consensus RatingHold Rating Score (0-4)2.41 Research Coverage22 Analysts Profitability EPS (Trailing Twelve Months)($1.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$245.03 million Net Margins-17.77% Pretax Margin-17.62% Return on Equity-50.28% Return on Assets-10.33% Debt Debt-to-Equity Ratio3.06 Current Ratio3.30 Quick Ratio3.16 Sales & Book Value Annual Sales$1.27 billion Price / Sales10.95 Cash FlowN/A Price / Cash FlowN/A Book Value$2.76 per share Price / Book27.97Miscellaneous Outstanding Shares180,430,000Free Float136,661,000Market Cap$13.93 billion OptionableN/A Beta3.72 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:TEM) was last updated on 9/22/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredA councilman backed AI — then 13 bullets hit his front doorThirteen bullets hit an Indianapolis councilman's front door days after he backed a data center rezoning. Acro...Stansberry Research | Sponsored“Elon Is Not Showing This Publicly, But I Saw It”Elon Musk quietly filed a patent for a new AI invention while attention focused on the SpaceX IPO. Jeff Brown,...Brownstone Research | SponsoredIran War WARNING: Something Just ChangedA powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...Banyan Hill Publishing | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredGold did this exact thing in 1975… [then exploded]In 1975 the Fed raised rates and gold fell 50 percent. Headlines called the gold bull market dead. Instead gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempus AI, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempus AI With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
